Inflammation‐Based Prognostication in Extensive‐Stage Small Cell Lung Cancer in the First‐Line Setting: The Advanced Lung Inflammation Index and the Others
CALLY, SII, ALI, and ECOG performance status could be useful prognostic markers for clinicians in patients with ES-SCLC receiving chemotherapy, with ALI emerging as the strongest prognostic factor. These readily accessible and easily computed markers can facilitate cost-effective follow-up and treatment decision-making by providing clinicians with a real-time assessment of the dynamic balance between host immunity and tumor-associated inflammation.
Authors
- Yıldız Garip Bilen (ORCID: https://orcid.org/0000-0003-2665-0522)
- Ercan Gedik (ORCID: https://orcid.org/0000-0002-5812-6998)
- S. Seber (ORCID: https://orcid.org/0000-0001-9081-2405)
- Okan Avcı (ORCID: https://orcid.org/0000-0003-3773-6620)
- Eyyüp Çavdar (ORCID: https://orcid.org/0000-0001-5885-3047)
- Ömer Faruk Elçiçek
- Özge Yalıcı (ORCID: https://orcid.org/0009-0002-0260-7511)
- İ. Karaduman (ORCID: https://orcid.org/0000-0003-4639-7464)
Institutions
- Tekirdağ Namık Kemal University (TR)
- Adıyaman University (TR)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1111/ajco.14200
- Citations
- 2
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.09